Preparation of polymer microspheres capable for pioglitazone release to modify macrophages function

Autor: Yasuhiko Tabata, Jun-ichiro Jo, Naoki Momotori
Rok vydání: 2019
Předmět:
0301 basic medicine
UV
ultra violet

PGA
poly(glycolic acid)

Pharmacology
chemistry.chemical_compound
PCR
polymerase chain reaction

0302 clinical medicine
Macrophage
M-CSF
macrophage colony stimulating factor

lcsh:R5-920
TNF
tumor necrosis factor

lcsh:Cytology
Chemistry
BMDM
mouse bone marrow derived-macrophage

PLGA
Interleukin
ELISA
enzyme-linked immunosorbent assay

Microspheres
PBS
phosphate buffered-saline solution

Arginase
HPLC
high performance liquid chromatography

Drug delivery
iNOS
inducible nitric oxide synthase

Original Article
DDW
double-distilled water

medicine.symptom
lcsh:Medicine (General)
PLA
poly(l-lactic acid)

medicine.drug
pio-MS
PLGA microspheres incorporating pioglitazone

Drug delivery system
Biomedical Engineering
Inflammation
Biomaterials
RS
resulting solution

03 medical and health sciences
FBS
fetal bovine serum

medicine
SEM
scanning electron microscopy

Secretion
lcsh:QH573-671
Pioglitazone
Macrophages
IMDM
Iscove's modified Dulbecco's medium

IL
interleukin

PPARγ
peroxisome proliferator-activated receptor γ

030104 developmental biology
PLGA
poly(L-lactic-co-glycolic acid)

SD
standard deviation

Poly(L-lactic-co-glycolic acid)
030217 neurology & neurosurgery
Developmental Biology
Zdroj: Regenerative Therapy
Regenerative Therapy, Vol 11, Iss, Pp 131-138 (2019)
ISSN: 2352-3204
Popis: Introduction Macrophages play an important role in regulating inflammation and tissue regeneration. It is known that anti-inflammatory macrophages play an important role for tissue regeneration. The objective of this study is to modify macrophages phenotypes for anti-inflammatory function by utilizing drug delivery technology. Method In this study, 4 types of poly (L-lactic-co-glycolic acid) (PLGA) microspheres incorporating pioglitazone of an anti-inflammatory modifier (pio-MS) with different sizes were prepared. In vitro release test of pio-MS was performed in phosphate buffered-saline solution (PBS) containing 1 wt% of sodium lauryl sulfate. The arginase activity and the secretion of interleukin (IL)−10 as anti-inflammatory macrophage markers of mouse bone marrow derived-macrophages (BMDM) cultured with the pio-MS were evaluated. Results The sustained release of pioglitazone was observed from all types of pio-MS in vitro. When BMDM were cultured with the pio-MS with an average diameter of 40 μm (pio-MS40), the arginase activity and the secretion of IL-10 increased to a significant extent compared with other pio-MS. Conclusions The pio-MS40 with an diameter of 40 μm had a potential to induce the anti-inflammatory modification of BMDM in this culture system. The sustained release of pioglitazone is promoting to modify the macrophage function.
Highlights • Microspheres incorporating pioglitazone with different sizes were prepared. • Sustained release of pioglitazone from the microspheres were observed. • The effect of pioglitazone on macrophages was enhanced by the sustained release.
Databáze: OpenAIRE